Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 127
of 7Next
1:

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C.

Poynard T, Imbert-Bismut F, Munteanu M, Messous D, Myers RP, Thabut D, Ratziu V, Mercadier A, Benhamou Y, Hainque B.

Comp Hepatol. 2004 Sep 23;3(1):8.

PMID: 15387887 [PubMed - as supplied by publisher]

2:

Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study.

Halfon P, Bourliere M, Deydier R, Botta-Fridlund D, Renou C, Tran A, Portal I, Allemand I, Bertrand JJ, Rosenthal-Allieri A, Rotily M, Sattonet C, Benderitter T, Saint Paul MC, Bonnot HP, Penaranda G, Degott C, Masseyeff MF, Ouzan D.

Am J Gastroenterol. 2006 Mar;101(3):547-55.

PMID: 16542291 [PubMed - indexed for MEDLINE]

3:

Discordance between biochemical markers of liver activity and fibrosis (Actitest((R))-Fibrotest((R))) and liver biopsy in patients with chronic hepatitis C.

Fontanges T, Bailly F, Trepo E, Chevallier M, Maynard-Muet M, Nalet B, Beorchia S, Pillon D, Moindrot H, Froissart B, Slaoui M, Tinel X, Pradat P, Trepo C.

Gastroenterol Clin Biol. 2008 Sep 3. [Epub ahead of print]

PMID: 18775614 [PubMed - as supplied by publisher]

4:

Meta-analyses of FibroTest diagnostic value in chronic liver disease.

Poynard T, Morra R, Halfon P, Castera L, Ratziu V, Imbert-Bismut F, Naveau S, Thabut D, Lebrec D, Zoulim F, Bourliere M, Cacoub P, Messous D, Munteanu M, de Ledinghen V.

BMC Gastroenterol. 2007 Oct 15;7:40.

PMID: 17937811 [PubMed - indexed for MEDLINE]

5:

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.

Ratziu V, Massard J, Charlotte F, Messous D, Imbert-Bismut F, Bonyhay L, Tahiri M, Munteanu M, Thabut D, Cadranel JF, Le Bail B, de Ledinghen V, Poynard T; LIDO Study Group; CYTOL study group.

BMC Gastroenterol. 2006 Feb 14;6:6.

PMID: 16503961 [PubMed - indexed for MEDLINE]

6:

Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.

Bourliere M, Penaranda G, Renou C, Botta-Fridlund D, Tran A, Portal I, Lecomte L, Castellani P, Rosenthal-Allieri MA, Gerolami R, Ouzan D, Deydier R, Degott C, Halfon P.

J Viral Hepat. 2006 Oct;13(10):659-70.

PMID: 16970597 [PubMed - indexed for MEDLINE]

7:

Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B.

Myers RP, Tainturier MH, Ratziu V, Piton A, Thibault V, Imbert-Bismut F, Messous D, Charlotte F, Di Martino V, Benhamou Y, Poynard T.

J Hepatol. 2003 Aug;39(2):222-30.

PMID: 12873819 [PubMed - indexed for MEDLINE]

8:

Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease.

Naveau S, Raynard B, Ratziu V, Abella A, Imbert-Bismut F, Messous D, Beuzen F, Capron F, Thabut D, Munteanu M, Chaput JC, Poynard T.

Clin Gastroenterol Hepatol. 2005 Feb;3(2):167-74.

PMID: 15704051 [PubMed - indexed for MEDLINE]

9:

Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection.

Poynard T, Zoulim F, Ratziu V, Degos F, Imbert-Bismut F, Deny P, Landais P, El Hasnaoui A, Slama A, Blin P, Thibault V, Parvaz P, Munteanu M, Trepo C.

Am J Gastroenterol. 2005 Sep;100(9):1970-80.

PMID: 16128941 [PubMed - indexed for MEDLINE]

10:

The FibroTest value in discriminating between insignificant and significant fibrosis in chronic hepatitis C patients. The Romanian experience.

Grigorescu M, Rusu M, Neculoiu D, Radu C, Serban A, Catanas M, Grigorescu MD.

J Gastrointestin Liver Dis. 2007 Mar;16(1):31-7.

PMID: 17410286 [PubMed - indexed for MEDLINE]

11:

Fibrotest-Actitest: the biochemical marker of liver fibrosis--the Israeli experience.

Morali G, Maor Y, Klar R, Braun M, Ben Ari Z, Bujanover Y, Zuckerman E, Boger S, Halfon P.

Isr Med Assoc J. 2007 Aug;9(8):588-91.

PMID: 17877064 [PubMed - indexed for MEDLINE]

12:

Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest).

Munteanu M, Messous D, Thabut D, Imbert-Bismut F, Jouys M, Massard J, Piton A, Bonyhay L, Ratziu V, Hainque B, Poynard T.

Comp Hepatol. 2004 Jun 23;3(1):3.

PMID: 15214966 [PubMed - as supplied by publisher]

13:

Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?

Maor Y, Bashari D, Kenet G, Lubetsky A, Luboshitz J, Schapiro JM, Pénaranda G, Bar-Meir S, Martinowitz U, Halfon P.

Haemophilia. 2006 Jul;12(4):372-9.

PMID: 16834736 [PubMed - indexed for MEDLINE]

14:

Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C.

Morra R, Munteanu M, Bedossa P, Dargere D, Janneau JL, Paradis V, Ratziu V, Charlotte F, Thibault V, Imbert-Bismut F, Poynard T.

Aliment Pharmacol Ther. 2007 Sep 15;26(6):847-58.

PMID: 17767469 [PubMed - indexed for MEDLINE]

15:

Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C.

Halfon P, Bacq Y, De Muret A, Penaranda G, Bourliere M, Ouzan D, Tran A, Botta D, Renou C, Bréchot MC, Degott C, Paradis V.

J Hepatol. 2007 Mar;46(3):395-402. Epub 2006 Nov 7.

PMID: 17156890 [PubMed - indexed for MEDLINE]

16:

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Castéra L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, Darriet M, Couzigou P, De Lédinghen V.

Gastroenterology. 2005 Feb;128(2):343-50.

PMID: 15685546 [PubMed - indexed for MEDLINE]

17:

An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load.

Ngo Y, Benhamou Y, Thibault V, Ingiliz P, Munteanu M, Lebray P, Thabut D, Morra R, Messous D, Charlotte F, Imbert-Bismut F, Rousselot-Bonnefont D, Moussalli J, Ratziu V, Poynard T.

PLoS ONE. 2008 Jul 2;3(7):e2573.

PMID: 18596917 [PubMed - indexed for MEDLINE]

18:

Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C.

Sebastiani G, Vario A, Guido M, Noventa F, Plebani M, Pistis R, Ferrari A, Alberti A.

J Hepatol. 2006 Apr;44(4):686-93. Epub 2006 Feb 8.

PMID: 16490278 [PubMed - indexed for MEDLINE]

19:

Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation.

Poynard T, Halfon P, Castera L, Charlotte F, Le Bail B, Munteanu M, Messous D, Ratziu V, Benhamou Y, Bourlière M, De Ledinghen V; FibroPaca Group.

Aliment Pharmacol Ther. 2007 Mar 15;25(6):733-9.

PMID: 17311607 [PubMed - indexed for MEDLINE]

20:

FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy.

Shaheen AA, Wan AF, Myers RP.

Am J Gastroenterol. 2007 Nov;102(11):2589-600. Epub 2007 Sep 10. Review.

PMID: 17850410 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 127
of 7Next